AndroGuider | One Stop For The Techy You!Neko Health Secures $700M to Revolutionize Health Assessme…
انتشار: 2026/07/16 01:11 UTC
AndroGuider | One Stop For The Techy You!Neko Health Secures $700M to Revolutionize Health Assessment with Body-Scanning Techai4chat-files.s3.amazonaws.com/images/ima… TL;DR* $700M Series C Funding: Neko Health, co-founded by Spotify CEO Daniel Ek, secured a $700 million Series C round led by Lightspeed Venture Partners, pushing its valuation to nearly $7 billion.* US Launch Plans: The startup will deploy the capital to open its first U.S. clinics in New York and other cities later in 2026, marking its expansion beyond Sweden and the UK.* Innovative Tech: Neko’s core offering combines in-house developed full-body medical scans with bloodwork to deliver comprehensive, preventive health assessments aimed at early disease detection. A $7 Billion Leap for Preventive CareStockholm-based health technology company Neko Health has officially closed a massive $700 million Series C funding round, cementing its status as a leader in the preventive healthcare sector. The round, announced on Wednesday, July 15, 2026, was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with significant participation from existing investors like Atomico, General Catalyst, and Lakestar, alongside new backers including Liberty City Ventures and BDT & MSD.This hyper-capitalized round propels Neko Health to a valuation of nearly $7 billion, representing a staggering fourfold increase from its $1.7 billion valuation just a year prior during its Series B in January 2025. The funding is strategically timed to support the company’s imminent entry into the United States, with its first flagship clinics set to open in Manhattan and other major cities later this year. The Vision: Redefining Preventive HealthcareFounded by Spotify CEO Daniel Ek and Hjalmar Nilsonne, Neko Health was built on the premise of shifting healthcare from reactive treatment to proactive prevention. The company aims to redefine how individuals understand and act on their health by providing accessible, comprehensive data before symptoms arise."The fundraise follows a $260m Series B in January 2025," marking a period of explosive growth for the startup as it scales its infrastructure to meet a global demand for early disease detection. With an active international waitlist of 350,000 people, Neko is deploying this capital to fuel its "across-the-pond" expansion, aiming to make its preventive scanning clinics a standard part of the US healthcare landscape. Inside the Technology: Body Scans + BloodworkNeko Health’s competitive edge lies in its proprietary, in-house developed full-body medical scanning technology. Unlike competitors that rely on third-party hardware, Neko builds its scanning capabilities internally, allowing for rapid, cost-effective feature upgrades and a more integrated diagnostic experience.The company’s assessment model is comprehensive, combining these advanced body scans with traditional bloodwork. This dual-approach provides a holistic view of a patient’s health, enabling the early detection of diseases and offering actionable insights for preventive care. By integrating these technologies, Neko aims to provide a "comprehensive health assessment" that goes beyond standard check-ups, identifying potential health risks with greater precision. An Elite Backing CoalitionThe $700 million round attracted an elite tier of global technology leaders and celebrity builders, signaling strong confidence in Neko’s trajectory. Notable new and existing investors include Mark Zuckerberg and Priscilla Chan, who have backed the company alongside tech innovator Tim Ferriss, tennis star Maria Sharapova, musician will.i.am, and OpenAI.The investment circle also includes high-profile figures [...]